Golden State Equity Partners Merck & Co., Inc. Transaction History
Golden State Equity Partners
- $470 Million
- Q2 2024
A detailed history of Golden State Equity Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 28,337 shares of MRK stock, worth $3.12 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
28,337
Previous 28,831
1.71%
Holding current value
$3.12 Million
Previous $3.14 Million
11.61%
% of portfolio
0.75%
Previous 0.78%
Shares
12 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$22.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.9 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.99 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.28 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $279B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...